THE VALUE OF CARCINOEMBRYONIC ANTIGEN (CEA) DETERMINATION IN PREDICTING DISEASE RECURRENCE (RD) IN BREAST-CANCER (BC) PATIENTS (PTS) TREATED WITH ADJUVANT CHEMOTHERAPY (ACT)

被引：0
|
作者：
THERIAULT, RL [1 ]
HORTOBAGYI, GN [1 ]
FRYE, D [1 ]
FRITSCHE, H [1 ]
HOLMES, FA [1 ]
BUZDAR, AU [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77030
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1988年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：199 / 199
页数：1
相关论文
共 50 条
  • [1] ROLE OF PLASMA CARCINOEMBRYONIC ANTIGEN IN EVALUATING PATIENTS WITH BREAST-CANCER TREATED WITH ADJUVANT CHEMOTHERAPY
    FALKSON, HC
    VANDERWATT, JJ
    PORTUGAL, MA
    SCHOEMAN, HS
    FALKSON, G
    CANCER TREATMENT REPORTS, 1979, 63 (08): : 1303 - 1309
  • [2] CARCINOEMBRYONIC ANTIGEN (CEA) IN PATIENTS WITH BREAST-CANCER
    BORTHWICK, NM
    WILSON, DW
    BELL, PA
    EUROPEAN JOURNAL OF CANCER, 1977, 13 (02) : 171 - 176
  • [3] THE ROLE OF THE CARCINOEMBRYONIC ANTIGEN (CEA) DETERMINATION IN BREAST-CANCER
    MAUSSIER, ML
    MARTINO, F
    SCHINCO, G
    TRONCONE, L
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1980, 5 (03): : A14 - A14
  • [4] THE RATE OF CARCINOEMBRYONIC ANTIGEN (CEA) PRODUCTION MAY BE A PROGNOSTIC FACTOR FOR BREAST-CANCER PATIENTS TREATED WITH CHEMOTHERAPY
    DISTEFANO, A
    HORTOBAGYI, GN
    TASHIMA, CK
    YAP, HY
    BUZDAR, AU
    BLUMENSCHEIN, GR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 156 - 156
  • [5] CARCINOEMBRYONIC ANTIGEN AS A MARKER IN PATIENTS WITH BREAST-CANCER RECEIVING POSTSURGICAL ADJUVANT CHEMOTHERAPY
    FALKSON, HC
    FALKSON, G
    PORTUGAL, MA
    VANDERWATT, JJ
    SCHOEMAN, HS
    CANCER, 1982, 49 (09) : 1859 - 1865
  • [6] PROGNOSTIC VALUE OF CARCINOEMBRYONIC ANTIGEN IN PATIENTS WITH BREAST-CANCER
    SMITH, JF
    SOUTHERN MEDICAL JOURNAL, 1977, 70 (06) : 722 - 724
  • [7] REUTILIZATION OF DOXORUBICIN (DX) IN BREAST-CANCER (BC) PATIENTS (PTS) WHO FAILED ADJUVANT CHEMOTHERAPY
    KAU, S
    FRASCHINI, G
    BUZDAR, A
    HORTOBAGYI, G
    BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (01) : 124 - 124
  • [8] SERIAL CARCINOEMBRYONIC ANTIGEN (CEA) DETERMINATIONS IN THE MANAGEMENT OF PATIENTS WITH BREAST-CANCER
    STAAB, HJ
    AHLEMANN, LM
    KOCH, HL
    ANDERER, FA
    ONCODEVELOPMENTAL BIOLOGY AND MEDICINE, 1980, 1 (03): : 151 - 160
  • [9] CARCINOEMBRYONIC ANTIGEN (CEA) IN THE FOLLOW-UP OF DISEASE-FREE BREAST-CANCER PATIENTS
    VERONESI, A
    TALAMINI, R
    LONGHI, S
    CRIVELLARI, D
    GALLIGIONI, E
    TIRELLI, U
    TROVO, MG
    MAGRI, MD
    FRUSTACI, S
    FIGOLI, F
    ZAGONEL, V
    TUMOLO, S
    GRIGOLETTO, E
    TUMORI, 1982, 68 (06) : 477 - 480
  • [10] CEA AS A MARKER IN PATIENTS WITH BREAST-CANCER RECEIVING POSTSURGICAL ADJUVANT CHEMOTHERAPY
    FALKSON, G
    FALKSON, HC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 405 - 405
12345